Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia

被引:56
作者
Quintanilla-Martinez, Leticia [1 ,2 ]
Sander, Birgitta [3 ,4 ]
Chan, John K. C. [5 ]
Xerri, Luc [6 ]
Ott, German [7 ,8 ]
Campo, Elias [9 ]
Swerdlow, Steven H. [10 ]
机构
[1] Univ Tubingen, Inst Pathol & Neuropathol, Liebermeisterstr 8, D-72076 Tubingen, Germany
[2] Univ Tubingen Hosp, Ctr Comprehens Canc, Liebermeisterstr 8, D-72076 Tubingen, Germany
[3] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden
[4] Karolinska Univ Hosp Huddinge, Stockholm, Sweden
[5] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[6] Inst J Paoli I Calmettes, Dept Biopathol, F-13009 Marseille, France
[7] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany
[8] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, Stuttgart, Germany
[9] Univ Barcelona, Hosp Clin, Barcelona, Spain
[10] Univ Pittsburgh, Sch Med, Dept Pathol, Div Hematopathol, Pittsburgh, PA USA
关键词
Indolent pediatric lymphomas; Pediatric-type follicular lymphoma; Pediatric nodal marginal zone lymphoma; IRF4/MUM1+lymphomas; Waldeyer's ring lymphomas; B-CELL LYMPHOMA; HIGH PROLIFERATION INDEX; NON-HODGKINS-LYMPHOMA; CLINICOPATHOLOGICAL ANALYSIS; TNFRSF14; MUTATIONS; NODULAR LYMPHOMA; CHILDREN; TESTIS; EXPRESSION; CHILDHOOD;
D O I
10.1007/s00428-015-1855-z
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Indolent lymphomas in the pediatric population were discussed during the 2014 European Association for Haematopathology/Society of Hematopathology workshop in Istanbul, Turkey. This session was focused on pediatric-type follicular lymphoma (FL), and its differential diagnosis with the newly recognized entity of IRF4/MUM1+ lymphomas mainly involving Waldeyer's ring. The differential diagnosis between t(14;18) negative FL grade 1/2 and pediatric-type FL in adults was highlighted. The overlapping pathological and clinical features between FL and nodal marginal zone lymphoma (NMZL) in children and young adults were recognized and morphologic and immunophenotypical criteria helpful for the differential diagnosis were presented. Both pediatric-type FL and NMZL are indolent processes that should be distinguished from atypical lymphoid hyperplasia of the tonsils and lymph nodes. The demonstration of a B cell monoclonal population by molecular studies is strongly recommended for the diagnosis. Recognition of these indolent variants to avoid overtreatment was emphasized. Whereas most indolent lymphomas in the pediatric population show characteristic clinical, pathologic, and genetic features that differ from the adult counterpart, other rare indolent lymphoid tumors such as chronic lymphocytic leukemia (CLL) have similar characteristics. In this report, novel findings, areas of special interest, and diagnostic challenges emerging from the cases submitted to the workshop will be discussed.
引用
收藏
页码:141 / 157
页数:17
相关论文
共 57 条
  • [1] The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas
    Adam, Patrick
    Baumann, Rosalie
    Schmidt, Janine
    Bettio, Sabrina
    Weisel, Katja
    Bonzheim, Irina
    Fend, Falko
    Quintanilla-Martinez, Leticia
    [J]. HUMAN PATHOLOGY, 2013, 44 (09) : 1817 - 1826
  • [2] [Anonymous], 2008, WHO CLASSIFICATION T
  • [3] Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "watch and wait" strategy after complete resection
    Attarbaschi, Andishe
    Beishuizen, Auke
    Mann, Georg
    Rosolen, Angelo
    Mori, Tetsuya
    Uyttebroeck, Anne
    Niggli, Felix
    Csoka, Monika
    Krenova, Zdenka
    Mellgren, Karin
    Kabickova, Edita
    Chiang, Alan K. S.
    Reiter, Alfred
    Williams, Denise
    Burkhardt, Birgit
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1537 - 1541
  • [4] Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction
    Attygalle, AD
    Liu, HX
    Shirali, S
    Diss, TC
    Loddenkemper, C
    Stein, H
    Dogan, A
    Du, MQ
    Isaacson, PG
    [J]. BLOOD, 2004, 104 (10) : 3343 - 3348
  • [5] Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols
    Burkhardt, B.
    Oschlies, I.
    Klapper, W.
    Zimmermann, M.
    Woessmann, W.
    Meinhardt, A.
    Landmann, E.
    Attarbaschi, A.
    Niggli, F.
    Schrappe, M.
    Reiter, A.
    [J]. LEUKEMIA, 2011, 25 (01) : 153 - 160
  • [6] Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
    Cheung, K-John J.
    Johnson, Nathalie A.
    Affleck, Joslynn G.
    Severson, Tesa
    Steidl, Christian
    Ben-Neriah, Susana
    Schein, Jacqueline
    Morin, Ryan D.
    Moore, Richard
    Shah, Sohrab P.
    Qian, Hong
    Paul, Jessica E.
    Telenius, Adele
    Relander, Thomas
    Lam, Wan
    Savage, Kerry
    Connors, Joseph M.
    Brown, Carolyn
    Marra, Marco A.
    Gascoyne, Randy D.
    Horsman, Douglas E.
    [J]. CANCER RESEARCH, 2010, 70 (22) : 9166 - 9174
  • [7] Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology
    Dores, Graca A. M.
    Anderson, William F.
    Curtis, Rochelle E.
    Landgren, Ola
    Ostroumova, Evgenia
    Bluhm, Elizabeth C.
    Rabkin, Charles S.
    Devesa, Susan S.
    Linet, Martha S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (05) : 809 - 819
  • [8] ElenitobaJohnson KSJ, 1997, AM J CLIN PATHOL, V107, P92
  • [9] A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
    Falini, B
    Fizzotti, M
    Pucciarini, A
    Bigerna, B
    Marafioti, T
    Gambacorta, M
    Pacini, R
    Alunni, C
    Natali-Tanci, L
    Ugolini, B
    Sebastiani, C
    Cattoretti, G
    Pileri, S
    Dalla-Favera, R
    Stein, H
    [J]. BLOOD, 2000, 95 (06) : 2084 - 2092
  • [10] Finn LS, 1999, CANCER, V85, P1626, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO